Opaleye Management Inc. 13D and 13G filings for Pasithea Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-31 4:05 pm Sale | 2026-06-30 | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Opaleye Management Inc. | 2,050,000 6.140% | -441,000 (-17.70%) | Filing |
| 2026-04-08 8:25 pm Purchase | 2026-04-01 | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Opaleye Management Inc. | 2,491,000 9.990% | 2,491,000 (New Position) | Filing |